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FURTHER STUDIES DEMONSTRATING AN INCREASED ERYTHEMAL
THRESHOLD FOLLOWING ORAL METHOXSALEN*
J. DONALD IMBRIE, M.D., LESTER L. BERGERON, B.A. AND THOMAS B.
FITZPATRICK, M.D., PH.D.
The use of methoxsalen or S-methoxypsoralen
to augment the normal skin response to ultra-
violet light has been intensively studied in recent
years. An extensive symposium on psoralens
and radiant energy was published in a supple-
ment to this journal in February, 1959 (1).
Included in that issue was a report by Imbrie,
et at. on increased erythemal threshold five
weeks after a single exposure to sunlight and
ingestion of 30 mg. of methoxsalen (2). In an
experimental group of eight young women, it
was shown that nearly twice as much ultraviolet
exposure was necessary to produce an erythema
on the methoxsalen treated skin as was needed
to produce a comparable amount on the control
area. However, these results were much more
impressive than were those obtained on men
receiving 20 mg. of methoxsalen with repetitive
solar exposures in Idaho and Arizona (3). Be-
cause of differences in drug dose, geographic
location and sex, further experiments were
required to explain the differences. This report
concerns a larger series of males to reaffirm the
magnitude of the protective effect and to in-
vestigate possible sex differences in response to
this drug.
METHODS
The experiment was done at the Oregon State
Prison in July and August, 1958. Nineteen male
volunteers were exposed to sunlight with aod
without oral methoxsalen. On the first exposure
day, the left side of the back of each man was
exposed to thirty minutes of noonday sun. The
subjects were in a prone position. Ten of the men
had taken 30 mg. of oral methoxsalen 234 hours
before exposure. The remaining nine received
identical-appearing placebos. The drugs were in
coded envelopes so that neither the observers nor
the subjects knew which preparation was first
received. On the second exposure day the prep-
arations were reversed, and the right side of the
back was exposed to 30 minutes of sunlight. Thus
each man had one-half of his back exposed to 30
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minutes of sunlight after taking 30 mg. meth-
oxsalen and the other half similarly exposed with-
out methoxsalen. The crossed design of the ex-
periment eliminated possible bias due to difference
in solar intensity on the two exposure days.
At intervals of three and five weeks after the
initial exposure, each side of the back received
graded challenge doses of ultraviolet light from
an R.S. G.E. 275 W reflector sunlamp. The lamp
was placed 15 inches from the back and delivered
17 E-vitons per square em. as measured by a
General Electric sunlamp tester. Small patches
on the side previously treated with methoxsalen
were exposed for intervals of two, four, six, and
eight minutes. Patches on the placebo side were
exposed for intervals of one, two, three and four
minutes.
Visual grading of erythema and pigment was
made on the same scale as used for previous
studies (2). Reflection readings were taken with
the Photovolt reflectance meter, model fi10-T (4).
Readings were taken with a red filter which pri-
marily measures melanin and not erythema, and
a Balzar's interference filter with peak transmit-
tance at 573 millimicrons, a wavelength at which
reflectance is very responsive to hemoglobin.
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RESULTS
Within one week after the sunlight exposure,
all the subj ects had more erythema and pig-
ment on the methoxsalen side of the back. These
differences persisted and the psoralcn side was
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obviously more pigmented on all men when
the challenge doses were given.
The visual gradings and 573 filter reflectance
differences from background were taken 24 hours
after the R.S. G.E. sunlamp challenger. Figures
1 and 2 show the results of the three week
challenge. Figures 3 and 4 show the results of
the challenge done at five weeks. The results
of both the three-week test and the five-week
test were similar and confirmed the previous
results. The side exposed to sunlight and methox-
salen had less erythemal response to a given
ultraviolet exposure than the side exposed with-
out methoxsalen. Linear regressions were com-
puted for the 573 filter reflectance for statistical
evaluation. The differences in response were
significant at the 5% level.
DISCUSSION
This experiment demonstrates that a marked
tolerance to ultraviolet light can be produced in
normal skin secondary to the effects of a single
dose of oral methoxsalen. This experiment was
done on males and confirms a previous study on
eight females. The magnitude of the increase in
tolerance is comparable in both studies. Both
sexes appear to respond equally well to 30 mg.
of oral methoxsalen.
The differences between previous studies (2,
3) were also resolved. The residual differences
are probably due to a major difference in the
effect of 30 mg. over 20 mg. One other doubt
remains—namely, that the 30 mg. exposures
were single ones. A low therapeutic ratio is
indicated for the methoxsalen; 20 mg. produces
only a slight effect; 30 mg. a very definite effect.
Limited studies in the past have indicated that
40, 50 and 75 mg. plus sunlight may produce
severe sunburning reactions.
SUMMARY
It was demonstrated in nineteen normal males
that a 30-minute exposure to sunlight two hours
after ingesting 30 mg. of methoxsalen will in-
crease the tolerance of the skin to subsequent
exposures of ultraviolet light. These findings
are in agreement with a previous experiment
on eight female subjects. The skin areas treated
with methoxsalen were exposed to ultraviolet
light at intervals of three and five weeks after
the initial exposure. In both eases the amount
of ultraviolet light required to produce a given
amount of erythcma on the skin previously
treated with methoxsalen was twice that necessary
to produce the same amount of crythema on the
skin that was exposed after subjects took
plaecbos.
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